In 2023, the global import of insulin was led by China, France, and Italy, with the highest values recorded in millions of US dollars. Noteworthy year-on-year variations included substantial increases in Norway, Netherlands, and Singapore, while the United States and Germany experienced declines. Emerging importer markets such as the Philippines saw impressive growth rates, indicating rising demand. Over five years, Saudi Arabia and Malaysia registered significant growth, driven by increased diabetic population and healthcare investment.
Future trends to watch include technological advancements in insulin production, increased adoption in emerging markets, and potential impacts of global health policies focusing on diabetes management, which could shift import landscapes significantly.
Top countries in Import of Insulin by Country
| # | 10 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 889,930,000 | 2023 | +5.31% | +5.09% | View data |
| 2 | 2 France | 738,430,000 | 2023 | +1.15% | +1.6% | View data |
| 3 | 3 Italy | 598,840,000 | 2023 | +4.91% | +5.07% | View data |
| 4 | 4 Russia | 109,960,000 | 2023 | +3.82% | +0.61% | View data |
| 5 | 5 United States | 75,475,000 | 2023 | -5.78% | -5.56% | View data |
| 6 | 6 India | 30,290,000 | 2023 | -0.62% | -0.56% | View data |
| 7 | 7 Egypt | 23,944,000 | 2023 | +4.69% | +0.79% | View data |
| 8 | 8 Ukraine | 7,104,700 | 2023 | -0.53% | -2.87% | View data |
| 9 | 9 Singapore | 5,961,500 | 2023 | +4.37% | +10.75% | View data |
| 10 | 10 Belarus | 5,432,100 | 2023 | +3.19% | +3.76% | View data |
